1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Reckitt Benckiser Group plc
  6. News
  7. Summary
    RB.   GB00B24CGK77

RECKITT BENCKISER GROUP PLC

(RB.)
  Report
Real-time Estimate Cboe Europe  -  03:42 2022-08-16 am EDT
6566.00 GBX   +0.24%
08/12RECKITT BENCKISER : Climate change is a threat to humanity's future
PU
08/11Reckitt Benckiser Group plc Announces Directorate Change
CI
08/11RECKITT BENCKISER : FDA Approves Importing of PurAmino Formula to US
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Danone, Reckitt race to ramp up US baby formula supply amid shortage

05/25/2022 | 03:41am EDT
FILE PHOTO: Logo of French food group Danone at the company headquarters in Rueil-Malmaison

LONDON, May 25 (Reuters) - Danone SA has been doubling shipments to the United States of Neocate formula for infants allergic to cow's milk while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said on Wednesday.

Top manufacturer Abbott Laboratories in February recalled dozens of types of its Similac, Alimentum and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.

Reckitt said it is working "extremely closely" with the U.S. Food & Drug Administration (FDA) on ways to increase supply, including expediting the approval of some products made at a facility in Mexico.

"Accelerating this process, while still ensuring high safety and quality standards, would allow us to significantly increase supply to U.S. consumers," Robert Cleveland, Reckitt's Senior Vice President of North America and Europe Nutrition, said in prepared remarks that he may read later on Wednesday at a hearing with U.S. lawmakers on the shortages.

The British company, which supplies roughly half the U.S. baby formula market, said it is also working with the U.S. Department of Agriculture (USDA) to expand the availability of formula under a program that helps low-income families.

Danone - the world's second-biggest baby formula maker after Nestle but a relatively small player in the United States with less than 5% of market share - is stepping up supply of Neocate more broadly.

“The Abbott recall affected 38 markets – it’s not only the U.S.," said Magdalena Broseta, Danone's Vice President General Counsel of Specialized Nutrition.

"Our factory in Europe is serving multiple markets...of course, the numbers and the volumes and the U.S. are bigger just because of the size of the market.”

The French company declined to say how many cans or tonnes of product it is exporting.

When asked if Danone would bring its flagship Aptamil formula into the United States, Broseta said the company had been discussing a number of options with authorities, adding that it was easier to increase imports of products that were already available in the country than introduce new ones.

"Their focus is to try to unblock any logistical situations that other players could be facing," she added. "It's a bit early to say what exactly would that entail."

Broseta said Danone is producing more formula at its plant in Liverpool, Britain and not rerouting product from elsewhere.

“We will keep on serving our existing geographies at the level of their respective demand," she said.

(Reporting by Richa Naidu Editing by David Goodman, Kirsten Donovan)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 0.38% 111.9 Delayed Quote.-20.49%
DANONE 1.23% 54.37 Real-time Quote.-1.67%
NESTLÉ S.A. -0.22% 115.38 Delayed Quote.-9.26%
RECKITT BENCKISER GROUP PLC 0.58% 6588 Delayed Quote.3.28%
S&P GSCI CLASS III MILK (USD) 2.11% 157.8588 Real-time Quote.-1.74%
All news about RECKITT BENCKISER GROUP PLC
08/12RECKITT BENCKISER : Climate change is a threat to humanity's future
PU
08/11Reckitt Benckiser Group plc Announces Directorate Change
CI
08/11RECKITT BENCKISER : FDA Approves Importing of PurAmino Formula to US
PU
08/11RECKITT BENCKISER GROUP PLC : Nomination
CO
08/05RECKITT BENCKISER GROUP PLC : Nomination
CO
08/04RECKITT BENCKISER GROUP PLC : Ex-dividend day for interim dividend
FA
08/02MARTIN SORRELL : Sorrell's S4 Capital bolsters board with Colin Day appointment
RE
08/01Morgan Stanley Lifts Reckitt Benckiser PT, Keeps Overweight Rating
MT
07/31RECKITT BENCKISER GROUP PLC : Monthly statement on outstanding equity shares and voting ri..
CO
07/29Goldman Sachs Keeps Reckitt Benckiser At Neutral, Boosts PT
MT
More news
Analyst Recommendations on RECKITT BENCKISER GROUP PLC
More recommendations
Financials
Sales 2022 14 220 M 17 173 M 17 173 M
Net income 2022 2 411 M 2 912 M 2 912 M
Net Debt 2022 7 280 M 8 792 M 8 792 M
P/E ratio 2022 19,5x
Yield 2022 2,73%
Capitalization 46 871 M 56 606 M 56 606 M
EV / Sales 2022 3,81x
EV / Sales 2023 3,58x
Nbr of Employees 40 000
Free-Float 96,9%
Chart RECKITT BENCKISER GROUP PLC
Duration : Period :
Reckitt Benckiser Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RECKITT BENCKISER GROUP PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 6 550,00 GBX
Average target price 7 400,81 GBX
Spread / Average Target 13,0%
EPS Revisions
Managers and Directors
Laxman Narasimhan Group Chief Executive Officer & Executive Director
Jeff Carr Chief Financial Officer & Executive Director
Christopher A. Sinclair Chairman
Nicandro Durante Senior Independent Non-Executive Director
Pamela J. Kirby Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RECKITT BENCKISER GROUP PLC3.28%56 606
PROCTER & GAMBLE COMPANY-9.18%350 476
UNILEVER PLC-0.33%120 512
THE ESTÉE LAUDER COMPANIES INC.-25.35%98 406
HINDUSTAN UNILEVER LIMITED9.98%76 583
COLGATE-PALMOLIVE COMPANY-4.80%66 972